AI
Wednesday, December 29, 2021 3:48:58 AM
Just a reminder - yesterday again a very high amount of 43.4% of the shares traded (and reported by FINRA) have been shorted and as a result, the shorts managed to keep the PPS down (as they did with an increase of short trading over the last few days). With all the facts and clarifications that we got in the latest Letter to Shareholders and the information nicely summarised in the fact sheet below (see link), it should just be a matter of time until Multikine will be approved by the FDA and the heavy manipulation by the shorts will come to an end after all those years they have been attacking Cel-Sci (it will be fun to see how they want to cover their 8.6 million shares
). I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!! Daily Short Volume Ratio (fintel.io, FINRA)
2021-12-28 43.48%
2021-12-27 38.31%
2021-12-23 36.79%
2021-12-22 28.18%
https://cel-sci.com/wp-content/uploads/2021/07/CVM_FactSheet_website_072021.pdf
Recent CVM News
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
